Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Micropace
AddedFeb 17, 2024
UpdatedJun 18, 2026
Micropace

Micropace

Micropace designs and manufactures EP cardiac stimulators, enhancing EP lab efficiency and advancing clinical research globally.

HQ
Santa Ana, CA, US
Founded
1995
Overview
Compare
Fundraising
Employees
Website

Micropace, founded with a mission to enhance the efficiency of electrophysiology (EP) labs and advance clinical research globally, designs and manufactures EP cardiac stimulators. Their flagship product, the EPS320B Cardiac Stimulator, is known for its intuitive graphical interface, intelligent automation, and pre-programmed protocols, allowing even new or rotating staff to operate it with minimal training. Micropace's product lineup includes the EPS320™, StimLab™, StimCor™, OneStim, OneLINK™, and SureTouch SW 4.0, all aimed at improving patient outcomes and lab productivity.

Notable figures associated with Micropace include experienced professionals in the medical device industry and investors focused on healthcare innovation. The company has achieved significant milestones in product development and market penetration, gaining recognition for its user-friendly and reliable cardiac stimulators. Micropace's impact is evident in the improved workflow and enhanced capabilities of EP labs worldwide, contributing to better patient care and advancing the field of cardiac electrophysiology.

Micropace - Similar Companies

EpiEP logo

EpiEP

epiep.com

NeuroPace logo

NeuroPace

neuropace.com

Pace mate logo

Pace mate

pacemate.com

Epic Neuro logo

Epic Neuro

Micron Solutions logo

Micron Solutions

iRhythm logo

iRhythm

irhythmtech.com

Innerpulse logo

Innerpulse

RhythmScience logo

RhythmScience

Micro-Leads logo

Micro-Leads

Swift Sync logo

Swift Sync

swiftsync.net

Oscor logo

Oscor

Phoenix Cardiac logo

Phoenix Cardiac

MicroPort Scientific logo

MicroPort Scientific

East End Medical logo

East End Medical

Epsilon Imaging logo

Epsilon Imaging

Micropace - Quick Facts

Who are Micropace's competitors?

Companies similar to Micropace include EpiEP, NeuroPace, Pace mate and Epic Neuro.

When was Micropace founded?

Micropace was founded in 1995.

Where is Micropace's headquarters located?

Micropace's headquarters is located in Santa Ana, CA, US.

When was Micropace's last funding round?

Micropace's most recent funding round was for $35M (USD) in November 2021.

How much has Micropace raised to-date?

As of Nov 1, 2021, Micropace has raised a total of $35M (USD).

How many employees does Micropace have?

Micropace has 30 employees as of Feb 4, 2024.

Micropace - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Medical Devices
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cardiac Stimulators
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified